Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

 

Enter Stock Symbol:  

Charles River Laboratories Intl (CRL)

104.13 -1.55 (-1.47%)

05-25 16:02

Open:

105.49

Pre. Close:

105.68

High:

105.9

Low:

103.97

Volume:

227,455

Market Cap:

4989M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

106.126 - 106.764

106.764 - 107.238

Low:

102.442 - 103.291

103.291 - 103.921

Close:

103.023 - 104.268

104.268 - 105.192

Technical analysis  (as of: 2018-05-25 4:33:27 PM)

Overall:

      

Stoxline posted a STRONG SELL today, downgraded from higher rating. This stock seems to be very strong for short side. So you may continue to hold the short positions or sell your long positions. You are relatively safe to short or sell as long as the BUY warning is not issued.

Target:

Six months: 123.79     One year: 125.98

Support:

Support1: 102.96    Support2: 85.66

Resistance:

Resistance1: 105.99    Resistance2: 107.86

Pivot:

105.42

Moving Averages:

MA(5): 105.92     MA(20): 105.31

MA(100): 106.80     MA(250): 105.37

MACD:

MACD(12,26): -0.11     Signal(12,26,9): -0.16

%K %D:

%K(14,3): 51.74     %D(3): 65.81

RSI:

RSI(14): 43.70

52-Week:

High: 119.05  Low: 91.47  Change(%): 13.4

Average Vol(K):

3-Month: 33111  10-Days 31109

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.
CRL has closed above bottom band by 18.2%. Bollinger Bands are 51.8% narrower than normal. The narrow width of the bands suggests low volatility as compared to CRL's normal range. The bands have been in this narrow range for 20 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

2018-05-16T13:59:09-04:00
Charles River Laboratories (CRL) Presents At Bank of America Merrill Lynch 2018 Healthcare Conference - Slideshow

2018-05-10T15:15:33-04:00
Charles River Laboratories International, Inc. 2018 Q1 - Results - Earnings Call Slides

2018-05-10T12:45:09-04:00
Charles River Laboratories International (CRL) Q1 2018 Results - Earnings Call Transcript

2018-05-10T07:53:28-04:00
Charles River Labs Q1 top line up 11%; earnings up 13%; cash flow up 77%

2018-05-10T07:01:25-04:00
Charles River Laboratories beats by $0.12, beats on revenue

2018-05-10T07:00:00-04:00
Charles River Laboratories Announces First-Quarter 2018 Results from Continuing Operations

2018-05-09T17:30:14-04:00
Notable earnings before Thursday's open

2018-05-07T14:07:54-04:00
Icon PLC Enjoying Wall Street Bonanza And FDA Tailwind

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Biotechnology Medical Research

Shares Out. (M)

47.95

Shares Float (M)

46.10

% Held by Insiders

3.90

% Held by Institutions

Shares Short (K)

1286

Shares Short Prior Month (K)

1110

Stock Financials

EPS

5.370

EPS Est. Current Year

5.100

EPS Est. Next Year

5.610

EPS Est. Next Quarter

1.300

Forward EPS

6.571

Book Value (p.s.)

4.800

PEG Ratio

1.68

Profit Margin

5.56

Operating Margin

16.46

Return on Assets (ttm)

4.4

Return on Equity (ttm)

13.1

Qtrly Rev. Growth

10.8

Gross Profit (p.s.)

11.066

Sales Per Share

EBITDA (p.s.)

7.100

Qtrly Earnings Growth

12.50

Operating Cash Flow (M)

342.12

Levered Free Cash Flow (M)

213.55

atoplab.com

Valuation

P/E

19.39

P/E Growth Ratio

-0.01

P/BV

21.69

P/S

124441712.00

P/CF

14.59

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.